6 Einträge gefunden

1. Assessment of imatinib as first-line treatment of chronic myeloid leukemia:10-year survival results of the randomized CML study IV and impact of non-CML determinants

   1. Hehlmann, R
   2. Lauseker, M
   3. Saußele, S
   4. Pfirrmann, M
   5. Krause, S
   6. Kolb, H J
   7. Neubauer, A

   2017 - Forschungsinformationssystem des UKE
2. The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis

   1. Ruutu, T
   2. Gratwohl, A
   3. Niederwieser, D
   4. de Witte, T
   5. van der Werf, S
   6. van Biezen, A
   7. Mohty, M

   2017 - Forschungsinformationssystem des UKE
3. Alloreactivity: the Janus-face of hematopoietic stem cell transplantation

   1. Gratwohl, A
   2. Sureda, A
   3. Cornelissen, J
   4. Apperley, J
   5. Dreger, P
   6. Duarte, R
   7. Greinix, H T

   2017 - Forschungsinformationssystem des UKE
4. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia-A randomized comparison of stem cell transplantation with drug treatment

   1. Gratwohl, A
   2. Pfirrmann, M
   3. Zander, A
   4. Kröger, N
   5. Beelen, D
   6. Novotny, J
   7. Nerl, C

   2016 - Forschungsinformationssystem des UKE
5. Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT

   1. Ruutu, T
   2. de Wreede, L C
   3. van Biezen, A
   4. Brand, R
   5. Mohty, M
   6. Dreger, P
   7. Duarte, R

   2015 - Forschungsinformationssystem des UKE
6. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice

   1. Ruutu, T
   2. Gratwohl, A
   3. de Witte, T
   4. Afanasyev, B
   5. Apperley, J
   6. Bacigalupo, A
   7. Dazzi, F

   2014 - Forschungsinformationssystem des UKE